Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03840902
Title M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors EMD Serono Research & Development Institute, Inc.

lung non-small cell carcinoma


Carboplatin + Paclitaxel


Cisplatin + Etoposide


Cisplatin + Etoposide + M7824

Carboplatin + M7824 + Paclitaxel

Cisplatin + M7824 + Pemetrexed Disodium

Cisplatin + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | CAN | BEL

Additional content available in CKB BOOST